Cerebral Blood Flow and Other Predictors of Responsiveness to Erenumab and Fremanezumab in Migraine—A Real-Life Study

INTRODUCTION: Monoclonal antibodies (mAbs) showed efficacy in migraine prevention. The aim of this study was to check if baseline clinical parameters and cerebral blood flow (CBF) measured by transcranial Doppler (TCD) may help predict mAbs efficacy. METHODS: Electronic charts of migraineurs treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Nowaczewska, Magdalena, Straburzyński, Marcin, Waliszewska-Prosół, Marta, Meder, Grzegorz, Janiak-Kiszka, Joanna, Kaźmierczak, Wojciech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152143/
https://www.ncbi.nlm.nih.gov/pubmed/35655615
http://dx.doi.org/10.3389/fneur.2022.895476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152143/
https://www.ncbi.nlm.nih.gov/pubmed/35655615
http://dx.doi.org/10.3389/fneur.2022.895476

Ejemplares similares